{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-23-024388","form_type":"8-K","ticker":"FORA","cik":"0001829280","company_name":"Forian Inc.","filed_at":"2023-05-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.956074+00:00","generated_at":"2026-06-15T02:44:49.865815+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Forian Q1 revenue up 38% to $4.9M; continuing ops loss narrows to $2.2M","bullets":["Revenue $4.87M, +38% YoY; continuing ops net loss $2.25M vs $10.3M loss in prior year.","Adjusted EBITDA from continuing ops improved to -$0.27M from -$2.7M YoY.","Discontinued ops contributed $8.7M net income from February 2023 sale of BioTrack cannabis business.","Cash, cash equivalents and marketable securities totaled $40M at March 31, 2023.","Company transitions to pure-play healthcare information provider after divesting cannabis software."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-23-024388","json":"https://secwatch.observer/filing/0001140361-23-024388.json","markdown":"https://secwatch.observer/filing/0001140361-23-024388.md","text":"https://secwatch.observer/filing/0001140361-23-024388.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1829280/000114036123024388/0001140361-23-024388-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1829280/000114036123024388/brhc20052853_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T02:44:49.865815+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"dc03060295eb5f25944608ae0eb021e80ac49ef9","claim":"Forian Inc. reported quarter ended March 31, 2023 results: revenue $4,870,387, net income $6,498,479, EPS $0.19.","evidence_excerpt":"● Forian delivered the following results for the first quarter of 2023: Three Months Ended March 31, Period- over- Period % Change 2023 Unaudited 2022 Unaudited Total revenue $ 4,870,387 $ 3,534,861 38% Loss from continuing operations, net of tax $ (2,248,799 ) $ (10,317,700 ) 78% Income (loss) from discontinued operations, net of tax $ 8,747,278 $ (1,536,388 )","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1829280/000114036123024388/0001140361-23-024388-index.htm","confidence":0.85,"family_label":"Earnings Releases","details":[{"label":"Period","value":"quarter ended March 31, 2023"},{"label":"Revenue","value":"$4,870,387"},{"label":"Net income","value":"$6,498,479"},{"label":"EPS","value":"$0.19"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}